Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             31 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A perspective on risks that impede development of drugs to modify the course of Alzheimer’s disease: Can they be reduced? Mohs, Richard C.
2008
1S1 p. S85-S87
3 p.
artikel
2 Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer’s disease Poirier, Judes
2008
1S1 p. S91-S97
7 p.
artikel
3 A quarter century of advancing treatment for Alzheimer’s disease with Leon J. Thal Grundman, Michael
2008
1S1 p. S51-S55
5 p.
artikel
4 Challenges in clinical research on Alzheimer’s disease: Leon Thal’s legacy Petersen, Ronald C.
2008
1S1 p. S88-S90
3 p.
artikel
5 Chronic disease long-term drug prevention trials: Lessons from the Alzheimer’s Disease Anti-inflammatory Prevention Trial (ADAPT) Meinert, Curtis L.
2008
1S1 p. S7-S14
8 p.
artikel
6 Contents 2008
1S1 p. A3-
1 p.
artikel
7 Contents 2008
1S1 p. A4-
1 p.
artikel
8 Current and future management of Alzheimer’s disease Gauthier, Serge
2008
1S1 p. S48-S50
3 p.
artikel
9 Current challenges for the successful treatment and prevention of Alzheimer’s disease: Treating the pathologies of the disease to change its clinical course Schenk, Dale
2008
1S1 p. S119-S121
3 p.
artikel
10 Dementia: Is it time for a change in focus? Kuller, Lewis H.
2008
1S1 p. S77-S84
8 p.
artikel
11 Differentiating Alzheimer’s disease from dementia with Lewy bodies and Parkinson’s disease with (+)-[11C]dihydrotetrabenazine positron emission tomography Koeppe, Robert A.
2008
1S1 p. S67-S76
10 p.
artikel
12 Disease-modifying approaches to Alzheimer’s disease: Challenges and opportunities—Lessons from donepezil therapy Sabbagh, Marwan N.
2008
1S1 p. S109-S118
10 p.
artikel
13 Drug discovery and the prevention of Alzheimer’s disease Fillit, Howard
2008
1S1 p. S26-S28
3 p.
artikel
14 Editorial board 2008
1S1 p. A5-
1 p.
artikel
15 Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer’s disease Jackson, Colleen E.
2008
1S1 p. S137-S143
7 p.
artikel
16 Eyes on the prize: Federal Alzheimer’s research effort aims to facilitate interventions Hodes, Richard J.
2008
1S1 p. S37-S47
11 p.
artikel
17 Home-based technologies: A new paradigm for conducting dementia prevention trials Kaye, Jeffrey
2008
1S1 p. S60-S66
7 p.
artikel
18 Leon Joel Thal, MD, 1944–2007: Honoring his scientific legacy Khachaturian, Zaven S.
2008
1S1 p. S1-S3
3 p.
artikel
19 Leon Thal and the therapeutic age of Alzheimer’s disease Aisen, Paul S.
2008
1S1 p. S4-S6
3 p.
artikel
20 Leon Thal’s vision for the treatment and prevention of Alzheimer’s disease Weiner, Michael W.
2008
1S1 p. S150-S152
3 p.
artikel
21 Medical and scientific advisory council 2008
1S1 p. A6-
1 p.
artikel
22 Memory health clinics—a first step to prevention Vellas, Bruno
2008
1S1 p. S144-S149
6 p.
artikel
23 More than a decade of estrogen neuroprotection Simpkins, James W.
2008
1S1 p. S131-S136
6 p.
artikel
24 Optimizing phase II of drug development for disease-modifying compounds Cummings, Jeffrey L.
2008
1S1 p. S15-S20
6 p.
artikel
25 Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses Cansev, Mehmet
2008
1S1 p. S153-S168
16 p.
artikel
26 Prevention therapeutics of dementia Schneider, Lon S.
2008
1S1 p. S122-S130
9 p.
artikel
27 Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer’s disease Foster, Norman L.
2008
1S1 p. S29-S36
8 p.
artikel
28 Subscriber information page 2008
1S1 p. A2-
1 p.
artikel
29 The oldest old and the 90+ Study Kawas, Claudia H.
2008
1S1 p. S56-S59
4 p.
artikel
30 The pre–mild cognitive impairment, subjective cognitive impairment stage of Alzheimer’s disease Reisberg, Barry
2008
1S1 p. S98-S108
11 p.
artikel
31 We should not distinguish between symptomatic and disease-modifying treatments in Alzheimer’s disease drug development Doody, Rachelle S.
2008
1S1 p. S21-S25
5 p.
artikel
                             31 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland